source,leaf,paths
Root,No; Consider: Switching to an alternative agent or; Stopping drug,"Patient for Use and Evaluation of SERUM DRUG LEVELS -> Assess need for SDL -> Obtain SDL -> Obtain patient-specific parameters -> Using patient-specific data, determine pharmacokinetic parameters of drug being monitored for patient; Assess reported SDL -> Compliance with drug schedule? -> Yes; SDL obtained at correct time? -> Yes; Sample stored correctly? -> Yes; SDL obtained from appropriate site or IV port without contamination? -> Yes; Assess patient's clinical response -> Good response to drug therapy -> No signs of toxicity or other adverse drug event -> No; Consider: Switching to an alternative agent or; Stopping drug||Patient for Use and Evaluation of SERUM DRUG LEVELS -> Assess need for SDL -> Obtain SDL -> Obtain patient-specific parameters -> Using patient-specific data, determine pharmacokinetic parameters of drug being monitored for patient; Assess reported SDL -> Compliance with drug schedule? -> Yes; SDL obtained at correct time? -> Yes; Sample stored correctly? -> Yes; SDL obtained from appropriate site or IV port without contamination? -> Yes; Assess patient's clinical response -> Poor response to drug therapy -> No signs of toxicity or other adverse drug event -> SDL drawn at SS (if applicable)? -> Yes -> If indicated, correct SDL based on protein binding; Evaluate possible drug interactions and effect on SDL -> Level above therapeutic range -> No; Consider: Switching to an alternative agent or; Stopping drug||Patient for Use and Evaluation of SERUM DRUG LEVELS -> Assess need for SDL -> Obtain SDL -> Obtain patient-specific parameters -> Using patient-specific data, determine pharmacokinetic parameters of drug being monitored for patient; Assess reported SDL -> Compliance with drug schedule? -> Yes; SDL obtained at correct time? -> Yes; Sample stored correctly? -> Yes; SDL obtained from appropriate site or IV port without contamination? -> Yes; Assess patient's clinical response -> Poor response to drug therapy -> No signs of toxicity or other adverse drug event -> SDL drawn at SS (if applicable)? -> Yes -> If indicated, correct SDL based on protein binding; Evaluate possible drug interactions and effect on SDL -> Level below therapeutic range -> No; Consider: Switching to an alternative agent or; Stopping drug||Patient for Use and Evaluation of SERUM DRUG LEVELS -> Assess need for SDL -> Obtain SDL -> Obtain patient-specific parameters -> Using patient-specific data, determine pharmacokinetic parameters of drug being monitored for patient; Assess reported SDL -> Compliance with drug schedule? -> Yes; SDL obtained at correct time? -> Yes; Sample stored correctly? -> Yes; SDL obtained from appropriate site or IV port without contamination? -> Yes; Assess patient's clinical response -> Poor response to drug therapy -> No signs of toxicity or other adverse drug event -> No; Consider: Switching to an alternative agent or; Stopping drug||Patient for Use and Evaluation of SERUM DRUG LEVELS -> Assess need for SDL -> Obtain SDL -> Obtain patient-specific parameters -> Using patient-specific data, determine pharmacokinetic parameters of drug being monitored for patient; Assess reported SDL -> Compliance with drug schedule? -> Yes; SDL obtained at correct time? -> Yes; Sample stored correctly? -> Yes; SDL obtained from appropriate site or IV port without contamination? -> Yes; Assess patient's clinical response -> Signs of toxicity or other adverse drug event -> Drug clinically needed and no alternative agent available? -> No; Consider: Switching to an alternative agent or; Stopping drug"
